KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Net Income - Minority: 2009-2025

Historic Net Income - Minority for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Sep 2025 value amounting to -$4.0 million.

  • Teva Pharmaceutical Industries' Net Income - Minority rose 98.75% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year increase of 98.75%. This contributed to the annual value of -$7.0 million for FY2024, which is 98.87% up from last year.
  • As of Q3 2025, Teva Pharmaceutical Industries' Net Income - Minority stood at -$4.0 million, which was up 42.86% from -$7.0 million recorded in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Net Income - Minority ranged from a high of -$4.0 million in Q3 2025 and a low of -$987.0 million during Q2 2021.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Net Income - Minority value was -$265.0 million (recorded in 2024), while the average stood at -$311.1 million.
  • In the last 5 years, Teva Pharmaceutical Industries' Net Income - Minority dropped by 1.54% in 2021 and then spiked by 98.87% in 2024.
  • Teva Pharmaceutical Industries' Net Income - Minority (Quarterly) stood at -$966.0 million in 2021, then rose by 17.81% to -$794.0 million in 2022, then climbed by 21.91% to -$620.0 million in 2023, then soared by 98.87% to -$7.0 million in 2024, then soared by 98.75% to -$4.0 million in 2025.
  • Its Net Income - Minority stands at -$4.0 million for Q3 2025, versus -$7.0 million for Q2 2025 and -$7.0 million for Q1 2025.